Orgenesis Inc. (ORGS) financial statements (2021 and earlier)

Company profile

Business Address 20271 GOLDENROD LANE
GERMANTOWN, MD 20876
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
11/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4511164141
Cash and cash equivalents4511164141
Restricted cash and investments1      
Receivables31151111
Inventory, net of allowances, customer advances and progress billings022100 
Inventory022100 
Prepaid expense 111110
Other undisclosed current assets117211 
Total current assets:5026307482
Noncurrent Assets
Operating lease, right-of-use asset110
Property, plant and equipment324125540
Long-term investments and receivables031    
Long-term investments0      
Due from related parties 31    
Intangible assets, net (including goodwill)222932262526 
Goodwill91515111010 
Intangible assets, net (excluding goodwill)131417151517 
Derivative instruments and hedges   0   
Deposits noncurrent assets010    
Other noncurrent assets100000 
Prepaid pension costs  0
Other undisclosed noncurrent assets   100 
Total noncurrent assets:2867453329310
TOTAL ASSETS:7892754033392
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities101798762
Accounts payable91144531
Accrued liabilities 221110
Employee-related liabilities1433211
Taxes payable0      
Deferred revenue09
Debt0413462
Derivative instruments and hedges, liabilities    02 
Due to related parties   0000
Deferred revenue and credits411 
Other liabilities0      
Other undisclosed current liabilities6272220
Total current liabilities:1632171715165
Noncurrent Liabilities
Long-term debt and lease obligation822351  
Long-term debt, excluding current maturities713351  
Finance lease, liability01
Operating lease, liability18
Liabilities, other than long-term debt0010000
Liability, pension and other postretirement and postemployment benefits0000000
Other liabilities001    
Derivative instruments and hedges, liabilities    0  
Other undisclosed noncurrent liabilities 221771
Total noncurrent liabilities:92465871
Total liabilities:2555232223245
Stockholders' equity
Stockholders' equity attributable to parent, including:535281411(6)(3)
Common stock0000000
Treasury stock, value(0)      
Common stock, share subscribed but unissued, subscriptions receivable  21 10
Additional paid in capital140958855421413
Accumulated other comprehensive income (loss)1001(1)(1)(0)
Accumulated deficit(88)(89)(62)(44)(30)(21)(16)
Warrants and rights outstanding      1
Other undisclosed stockholders' equity attributable to parent      (1)
Stockholders' equity attributable to noncontrolling interest010    
Other undisclosed stockholders' equity   4 21 
Total stockholders' equity:53629181115(3)
Other undisclosed liabilities and equity 3124    
TOTAL LIABILITIES AND EQUITY:7892754033392

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
11/30/2014
Revenues833191063 
Revenue from related parties1  
Other operating income 03    
Cost of revenue (18)(11)(7)(8)(4) 
Gross profit:81583(1)(1) 
Operating expenses(103)(38)(23)(12)(8)(6)(5)
Other undisclosed operating income (loss)191(2)0(3)(2)  
Operating income (loss):96(25)(15)(11)(11)(7)(5)
Nonoperating income (expense)1(1)(3)(2)12(1)
Investment income, nonoperating    (0)  
Debt instrument, convertible, beneficial conversion feature      0
Other nonoperating income (expense)1(1)(3)(2)12(1)
Interest and debt expense(1)(0)(3)(1)(0)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes 031012
Income (loss) from continuing operations before equity method investments, income taxes:96(25)(18)(14)(11)(5)(5)
Other undisclosed income from continuing operations before income taxes1      
Income (loss) from continuing operations before income taxes:97(25)(18)(14)(11)(5)(5)
Income tax expense (benefit)(2)(1)(1)121 
Income (loss) from continuing operations:95(26)(19)(12)(9)(4)(5)
Loss from discontinued operations(96)      
Net loss:(1)(26)(19)(12)(9)(4)(5)
Net income attributable to noncontrolling interest 21    
Other undisclosed net loss attributable to parent(1)     (1)
Net loss attributable to parent:(1)(24)(18)(12)(9)(4)(6)
Other undisclosed net income (loss) available to common stockholders, basic(100)(4)37    
Net income (loss) available to common stockholders, basic:(101)(28)19(12)(9)(4)(6)
Interest on convertible debt  0    
Net income (loss) available to common stockholders, diluted:(101)(28)20(12)(9)(4)(6)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
11/30/2018
11/30/2017
11/30/2016
11/30/2015
11/30/2014
Net loss:(1)(26)(19)(12)(9)(4)(5)
Other comprehensive income (loss)2(25)(19)    
Other undisclosed comprehensive income 2418    
Comprehensive income (loss):1(26)(20)(12)(9)(4)(5)
Comprehensive income, net of tax, attributable to noncontrolling interest 21    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)  30(1)(1)
Comprehensive loss, net of tax, attributable to parent:(2)(25)(19)(10)(9)(6)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: